The road ahead: potential challenges facing CRISPR/Cas patents

09-11-2017

Patricia Carson and Ashley Ross

The road ahead: potential challenges facing CRISPR/Cas patents

Ralwel/istockphoto.com

Past successes by trailblazers in other biotechnological fields could assist potential patentees navigate legal bumps along the road to IP protection for CRISPR-related inventions, as Patricia Carson and Ashley Ross of Kirkland & Ellis describe.


Patricia Carson, Ashley Ross,Kirkland & Ellis, patent, CRISPR, CRISPR/Cas, patents, gene visualisation, UC berkeley, Eukaryotic, US Patent Trial and Appeal

LSIPR